[go: up one dir, main page]

FI941396A0 - Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten - Google Patents

Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten

Info

Publication number
FI941396A0
FI941396A0 FI941396A FI941396A FI941396A0 FI 941396 A0 FI941396 A0 FI 941396A0 FI 941396 A FI941396 A FI 941396A FI 941396 A FI941396 A FI 941396A FI 941396 A0 FI941396 A0 FI 941396A0
Authority
FI
Finland
Prior art keywords
compositions
biologically active
controlled release
active tgf
tgf
Prior art date
Application number
FI941396A
Other languages
English (en)
Swedish (sv)
Other versions
FI941396A (fi
Inventor
Wayne Richard Gombotz
Lisa Servito Bouchard
Susan Carol Pankey
Michael E Hawkins
Anthony F Purchio
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI941396A0 publication Critical patent/FI941396A0/fi
Publication of FI941396A publication Critical patent/FI941396A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI941396A 1993-03-26 1994-03-25 Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten FI941396A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3778693A 1993-03-26 1993-03-26

Publications (2)

Publication Number Publication Date
FI941396A0 true FI941396A0 (fi) 1994-03-25
FI941396A FI941396A (fi) 1994-09-27

Family

ID=21896328

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941396A FI941396A (fi) 1993-03-26 1994-03-25 Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten

Country Status (7)

Country Link
EP (1) EP0616814A1 (fi)
JP (1) JPH072691A (fi)
AU (1) AU5905694A (fi)
CA (1) CA2119090A1 (fi)
FI (1) FI941396A (fi)
IL (1) IL109032A0 (fi)
NO (1) NO940913L (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
GB9407135D0 (en) * 1994-04-11 1994-06-01 Aberdeen University And Plasma Treatment of osteoporosis
GB2301531B (en) * 1994-04-11 1997-12-17 Univ Aberdeen Intraosseus injection device
US5591453A (en) * 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5817327A (en) * 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
JPH08193997A (ja) * 1995-01-18 1996-07-30 Mitsubishi Materials Corp 活性型ＴＧＦ−β１の吸着剤、活性型ＴＧＦ−β１の検査法及び癌の検査法
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
JP2936314B2 (ja) 1995-12-06 1999-08-23 旭土建株式会社 保水性ネット
BR9707325A (pt) * 1996-02-09 1999-04-13 Amgen Inc Processo para o tratamento de um paciente afetado com uma doença mediada por il-1, composição farmacéutica e uso da mesma
ATE357264T1 (de) * 1996-10-24 2007-04-15 Sdgi Holdings Inc Keramische implantate und zusammensetzungen mit osteoinduktiven wirkstoffen
US6037519A (en) 1997-10-20 2000-03-14 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
US20030032586A1 (en) * 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
EP0902036A1 (en) 1997-09-05 1999-03-17 Roche Diagnostics GmbH Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6911553B1 (en) 1997-10-02 2005-06-28 Roche Diagnostics Gmbh Osteoblast-specific mitogens and drugs containing such compounds
EP0906759A1 (de) 1997-10-02 1999-04-07 Roche Diagnostics GmbH Neue Osteoblastenspezifische Mitogene: Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
NL1008582C2 (nl) * 1998-01-05 1999-07-06 Vrije Universiteit Botmateriaal.
AU3556400A (en) 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
US6726718B1 (en) 1999-12-13 2004-04-27 St. Jude Medical, Inc. Medical articles prepared for cell adhesion
US7635592B2 (en) 2000-08-21 2009-12-22 Rice University Tissue engineering scaffolds promoting matrix protein production
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
GB0110726D0 (en) 2001-05-02 2001-06-27 Biocomposites Ltd Bone implant composition
US8496955B2 (en) 2001-05-02 2013-07-30 Biocomposites Limited Calcium phosphate/sulfate-based bone implant composition
US7371258B2 (en) 2001-10-26 2008-05-13 St. Jude Medical, Inc. Valved prosthesis with porous substrate
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
WO2006066089A1 (en) 2004-12-15 2006-06-22 Neuralab Limited Humanized amyloid beta antibodies for use in improving cognition
DE102005040429A1 (de) * 2005-08-25 2007-03-01 Heraeus Kulzer Gmbh Wirkstofffreisetzungssystem und seine Verwendung
WO2007113682A2 (en) * 2006-04-06 2007-10-11 Novozymes Gropep Ltd Tgf-beta pharmaceutical compositions
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8133553B2 (en) 2007-06-18 2012-03-13 Zimmer, Inc. Process for forming a ceramic layer
US8309521B2 (en) 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
US8608049B2 (en) 2007-10-10 2013-12-17 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials
AU2009200540A1 (en) * 2008-07-03 2010-01-21 Induce Biologics Inc. Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
GB0911365D0 (en) 2009-06-30 2009-08-12 Bioceramic Therapeutics Ltd Multicomponent glasses for use as coatings and in personal care products
AU2011329054B2 (en) 2010-11-15 2015-05-28 Zimmer Orthobiologics, Inc. Bone void fillers
JP5966129B2 (ja) * 2011-01-31 2016-08-10 オリンパス株式会社 免疫賦活剤
EP3190089A4 (en) 2014-09-01 2018-06-20 Kyushu University, National University Corporation Method for manufacturing product inorganic compound and product inorganic compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
NL8401061A (nl) * 1984-04-04 1985-11-01 Stichting Biomaterials Science Werkwijze voor het bereiden van een implantatiemateriaal dat geneesmiddelen afgeeft in het lichaam.
US5108436A (en) * 1988-09-29 1992-04-28 Collagen Corporation Implant fixation
IE61346B1 (en) * 1988-11-02 1994-11-02 Genentech Inc A permeable material to fit around the teeth or gums of a mammal
US4976736A (en) * 1989-04-28 1990-12-11 Interpore International Coated biomaterials and methods for making same
CA2056384C (en) * 1989-06-05 1998-06-23 Tobin N. Gerhart Bioerodible polymers for drug delivery in bone
ZA923086B (en) * 1991-04-29 1993-10-28 South African Medical Research A delivery system for biologicaly active growth or morphogenetic factors and a method for preparing such delivery system
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone

Also Published As

Publication number Publication date
EP0616814A1 (en) 1994-09-28
IL109032A0 (en) 1994-06-24
NO940913L (no) 1994-09-27
JPH072691A (ja) 1995-01-06
FI941396A (fi) 1994-09-27
NO940913D0 (no) 1994-03-15
AU5905694A (en) 1994-09-29
CA2119090A1 (en) 1994-09-27

Similar Documents

Publication Publication Date Title
FI941396A0 (fi) Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten
DK1468679T3 (da) Tramadolholdig formulering med styret frigivelse
DE69321461D1 (de) Desinfizierende zusammensetzung
ITMI930990A0 (it) 3- (acilossifenil) benzofuran-2-oni come agenti stabilizzanti
ITMI930989A0 (it) 3-(carbossimetossifenil)-benzofuran-2-oni come agenti stabilizzanti
DE69325158D1 (de) Photokromische Zusammensetzung
ITMI922617A0 (it) Forme matriciali multistrato per il rilascio controllato di principi attivi
DE69322946D1 (de) Photolackzusammensetzung
DE59307628D1 (de) Kugelkopfendoprothese
DE69301999D1 (de) Photoresist Zusammensetzung
ES1022219Y (es) "ambientador de sobremesa"
KR950700911A (ko) 살균약제로서의 치환된 3-피롤리디닐티오-카르바페넴(Substituted 3-Pyrrolidinylthio-Carbapenems as Antimicrobial Agents)
EE04045B1 (et) Pidevalt toimeainena diltiaseemi vabastavad mikrograanulid
BR9305261A (pt) Composição implantável com liberação controlada
FI955161A (fi) Systeemejä pilokarpiinin säädeltyä vapauttamista varten
FI943871A0 (fi) Pidätyskyvyttömyyssuoja
BR9307470A (pt) Implante
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
DE69326721D1 (de) Insektizidzusammensetzung
DE69307830D1 (de) Insektizide Zusammensetzung
FR2695297B1 (fr) Composition d'agent désinfectant.
DE69307943D1 (de) Polyisocyanatzusammensetzung
FI933949A0 (fi) Implantat
DE69311219D1 (de) Silikontrennschicht-Zusammensetzung
DE69217904D1 (de) Zusammensetzung